Literature DB >> 1361886

Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine.

V M Pickel1, E Johnson, M Carson, J Chan.   

Abstract

Residual dopamine terminals in the dorsal striatum, caudate-putamen nuclei (CPN), of adult rats neonatally lesioned with 6-hydroxydopamine (6-OHDA) sustain a relatively high level of dopamine release. We examined whether there were morphological differences in the spared dopamine terminals that might correlate with this increased efficacy. Postnatal male rat pups from 50 litters were pretreated with desmethylimipramine (DMI) to protect from non-specific monoamine damage, then given unilateral intranigral injections of 6-OHDA or vehicle. Coronal sections through the CPN and substantia nigra of the surviving adult animals from each litter were co-processed for immunoautoradiographic or immunoperoxidase localization of the catecholamine synthesizing enzyme, tyrosine hydroxylase (TH). Quantitative ultrastructural analysis established that in animals showing maximal (greater than 90%) depletions in immunoautoradiographic labeling for TH, the number of TH-labeled axons in the CPN ipsilateral to the 6-OHDA injections was reduced to one third of the number seen in the contralateral, unlesioned hemisphere, or the CPN from vehicle-injected animals. The ultrastructural features of residual terminals ipsilateral to 6-OHDA lesions were morphologically similar to those of the contralateral side or in vehicle-injected animals. However, in comparison with controls, these TH-labeled terminals had significantly larger mean cross-sectional diameters. When subdivided into groups according to size, there were significantly fewer small (0.0-0.1 micron 2) and more large (0.41-0.50 micron 2) TH-immunoreactive profiles in lesioned versus unlesioned CPN. The remaining TH-labeled terminals ipsilateral to the 6-OHDA lesions also appeared to be more often in direct contact with unlabeled soma and proximal dendrites as opposed to dendritic spines in the unlesioned CPN. These results suggest that the enhanced activity of dopamine neurons innervating the CPN after nigral 6-OHDA lesions may contribute to changes in size and target of their terminals. Alternatively, the observed large size of remaining dopamine terminals may reflect selective vulnerability of smaller axons to 6-OHDA toxicity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361886     DOI: 10.1016/0165-3806(92)90105-6

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  8 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons.

Authors:  Amandine Berthet; Elyssa B Margolis; Jue Zhang; Ivy Hsieh; Jiasheng Zhang; Thomas S Hnasko; Jawad Ahmad; Robert H Edwards; Hiromi Sesaki; Eric J Huang; Ken Nakamura
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

3.  Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.

Authors:  Ana Luisa Gutierrez-Valdez; Verónica Anaya-Martínez; José Luis Ordoñez-Librado; Ricardo García-Ruiz; Carmen Torres-Esquivel; Montserrat Moreno-Rivera; Javier Sánchez-Betancourt; Enrique Montiel-Flores; Maria Rosa Avila-Costa
Journal:  ISRN Neurol       Date:  2012-02-01

4.  The Effects of Exercise on Dopamine Neurotransmission in Parkinson's Disease: Targeting Neuroplasticity to Modulate Basal Ganglia Circuitry.

Authors:  G M Petzinger; D P Holschneider; B E Fisher; S McEwen; N Kintz; M Halliday; W Toy; J W Walsh; J Beeler; M W Jakowec
Journal:  Brain Plast       Date:  2015

Review 5.  Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control.

Authors:  Luisa Speranza; Umberto di Porzio; Davide Viggiano; Antonio de Donato; Floriana Volpicelli
Journal:  Cells       Date:  2021-03-26       Impact factor: 6.600

6.  Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism.

Authors:  Leyre Merino-Galán; Haritz Jimenez-Urbieta; Marta Zamarbide; Tatiana Rodríguez-Chinchilla; Arantzazu Belloso-Iguerategui; Enrique Santamaria; Joaquín Fernández-Irigoyen; Ana Aiastui; Evelyne Doudnikoff; Erwan Bézard; Alberto Ouro; Shira Knafo; Belén Gago; Ana Quiroga-Varela; María Cruz Rodríguez-Oroz
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

7.  MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology.

Authors:  Jyothi K Mallajosyula; Deepinder Kaur; Shankar J Chinta; Subramanian Rajagopalan; Anand Rane; David G Nicholls; Donato A Di Monte; Heather Macarthur; Julie K Andersen
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

8.  ARG3.1/ARC expression in hippocampal dentate gyrus astrocytes: ultrastructural evidence and co-localization with glial fibrillary acidic protein.

Authors:  J J Rodríguez; H A Davies; M L Errington; A Verkhratsky; T V P Bliss; M G Stewart
Journal:  J Cell Mol Med       Date:  2008-04       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.